Tech Company Financing Transactions

SetPoint Medical Funding Round

On 1/19/2023, SetPoint Medical raised $80 million in funding from Norwest Venture Partners, Viking Global Investors and Action Potential Venture Capital.

Transaction Overview

Company Name
Announced On
1/19/2023
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to complete its ongoing RESET-RA trial and subsequent U.S. Food and Drug Administration (FDA) regulatory submissions and early commercialization for the rheumatoid arthritis indication.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
25101 Rye Canyon Loop
Valencia, CA 91355
USA
Email Address
Overview
SetPoint Medical is a biomedical technology company developing neuromodulation therapies for patients with inflammatory autoimmune diseases, such as rheumatoid arthritis and Crohn's Disease.
Profile
SetPoint Medical LinkedIn Company Profile
Social Media
SetPoint Medical Company Twitter Account
Company News
SetPoint Medical News
Facebook
SetPoint Medical on Facebook
YouTube
SetPoint Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Murthy Simhambhatla
  Murthy Simhambhatla LinkedIn Profile  Murthy Simhambhatla Twitter Account  Murthy Simhambhatla News  Murthy Simhambhatla on Facebook
Chief Medical Officer
David Chernoff
  David Chernoff LinkedIn Profile  David Chernoff Twitter Account  David Chernoff News  David Chernoff on Facebook
VP - Marketing
Ankit Shah
  Ankit Shah LinkedIn Profile  Ankit Shah Twitter Account  Ankit Shah News  Ankit Shah on Facebook
VP - Operations
John Long
  John Long LinkedIn Profile  John Long Twitter Account  John Long News  John Long on Facebook
VP - Product Management
William Calle
  William Calle LinkedIn Profile  William Calle Twitter Account  William Calle News  William Calle on Facebook
VP - R & D
Yaakov Levine
  Yaakov Levine LinkedIn Profile  Yaakov Levine Twitter Account  Yaakov Levine News  Yaakov Levine on Facebook
VP - Regulatory Affairs
Lusin Markaryan
  Lusin Markaryan LinkedIn Profile  Lusin Markaryan Twitter Account  Lusin Markaryan News  Lusin Markaryan on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/19/2023: ClearSpace venture capital transaction
Next: 1/19/2023: myInterview venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary